DFT Calculations and In silico Study of Chlorogenic, Ellagic and Quisqualic acids as Potential Inhibitors of SARS-CoV-2 Main Protease Mpro

被引:6
|
作者
Shahab, Siyamak [1 ,2 ,3 ]
Kaviani, Sadegh [4 ]
Sheikhi, Masoome [5 ]
Almodarresiyeh, Hora Alhosseini [6 ]
Al Saud, Sultan [1 ,3 ]
机构
[1] Belarusian State Univ, ISEI BSU, Minsk, BELARUS
[2] Natl Acad Sci Belarus, Inst Phys Organ Chem, 13 Surganov Str, Minsk 220072, BELARUS
[3] Natl Acad Sci Belarus, Inst Chem New Mat, 36 Skarina Str, Minsk 220141, BELARUS
[4] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Razavi Khorasan, Iran
[5] Islamic Azad Univ, Gorgan Branch, Young Researchers & Elite Club, Gorgan, Golestan, Iran
[6] Meybod Univ, Sch Engn, Dept Mat Sci & Engn, Meybod 8961699557, Yazd, Iran
来源
BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY | 2022年 / 12卷 / 01期
关键词
SARS-CoV-2 main protease M-pro; DFT; molecular docking; chlorogenic; Ellagic and Quisqualic acids; pharmacokinetic properties; COFFEE; METABOLITES; DERIVATIVES; DISCOVERY; TRANSPORT; UV/VIS; HUMANS;
D O I
10.33263/BRIAC121.061073
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
In the present work, at first, density functional theory calculations were performed to investigate the molecular structure of the Chlorogenic, Ellagic, and Quisqualic acids by CAM-B3LYP/MidiX level of theory. A detail of quantum molecular descriptors of the title compounds such as ionization potential (IP) and Electron Affinities (EA), Hardness (eta), Softness (S), Electronegativity (mu), Electrophilic Index (omega), Electron Donating Power (omega-), Electron Accepting Power (omega+) and Energy Gap (Eg) have been calculated. Pharmacokinetic properties of the title compounds and their bioactivity were investigated. In the following, a molecular docking study was carried out to screen for an effective available compound that may work as a strong inhibitor for the SARS-CoV-2 main protease Mpro. The binding energy between SARS-CoV-2 main protease Mpro and title organic acids showed a good binding affinity. Therefore, the Chlorogenic, Ellagic, and Quisqualic acids can be used for potential application against the SARS-CoV-2 main protease Mpro.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 50 条
  • [41] In Silico Comparative Analysis of Ivermectin and Nirmatrelvir Inhibitors Interacting with the SARS-CoV-2 Main Protease
    So, Yuri Alves de Oliveira
    Bezerra, Katyanna Sales
    Gargano, Ricardo
    Mendonca, Fabio L. L.
    Souto, Janeusa Trindade
    Fulco, Umberto L.
    Pereira Jr, Marcelo Lopes
    Ribeiro Jr, Luiz Antonio
    BIOMOLECULES, 2024, 14 (07)
  • [42] Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study
    Ibrahim, Mahmoud A. A.
    Mohamed, Eslam A. R.
    Abdelrahman, Alaa H. M.
    Allemailem, Khaled S.
    Moustafa, Mahmoud F.
    Shawky, Ahmed M.
    Mahzari, Ali
    Hakami, Abdulrahim Refdan
    Abdeljawaad, Khlood A. A.
    Atia, Mohamed A. M.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2021, 105
  • [43] Exploration of Some Naturally Occurring Fungal-Derived Bioactive Molecules as Potential SARS-CoV-2 Main Protease (MPro) Inhibitors Through In-silico Approach
    Jana, Pradip
    Bhardwaj, Bhagwati
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2021, 20 (03): : 251 - 266
  • [44] Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations
    Rudrapal, Mithun
    Celik, Ismail
    Khan, Johra
    Ansari, Mohammad Azam
    Alomary, Mohammad N.
    Alatawi, Fuad Abdullah
    Yadav, Rohitash
    Sharma, Tripti
    Tallei, Trina Ekawati
    Pasala, Praveen Kumar
    Sahoo, Ranjan Kumar
    Khairnar, Shubham J.
    Bendale, Atul R.
    Zothantluanga, James H.
    Chetia, Dipak
    Walode, Sanjay G.
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2022, 34 (03)
  • [45] In silico and in vitro assays reveal potential inhibitors against 3CLpro main protease of SARS-CoV-2
    Iype, Eldhose
    Jisha, Pillai U.
    Kumar, Indresh
    Gaastra-Nedea, Silvia V.
    Subramanian, Ramachandran
    Saha, Ranendra Narayan
    Dutta, Mainak
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (23) : 12800 - 12811
  • [46] Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study
    Llanos, Manuel A.
    Gantner, Melisa E.
    Rodriguez, Santiago
    Alberca, Lucas N.
    Bellera, Carolina L.
    Talevi, Alan
    Gavernet, Luciana
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2021, 61 (08) : 3758 - 3770
  • [47] DFT, Molecular Docking, ADME, and Cardiotoxicity Studies of Persuasive Thiazoles as Potential Inhibitors of the Main Protease of SARS-CoV-2
    Khan, Muhammad Asim
    Mutahir, Sadaf
    Jabar, Gauhar
    Wenwei, Zhao
    Tariq, Muhammad Atif
    Almehizia, Abdulrahman A.
    Mustafa, Muhammad
    CHEMISTRY & BIODIVERSITY, 2024, 21 (12)
  • [48] In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
    Eleftheriou, Phaedra
    Amanatidou, Dionysia
    Petrou, Anthi
    Geronikaki, Athina
    MOLECULES, 2020, 25 (11):
  • [49] Flavonoids as potential inhibitors of SARS-CoV-2 infection: in silico study
    Taldaev, A. Kh
    Terekhov, R. P.
    Selivanova, I. A.
    BYULLETEN SIBIRSKOY MEDITSINY, 2022, 21 (01): : 103 - 108
  • [50] Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
    Jimenez-Alberto, Alicia
    Maria Ribas-Aparicio, Rosa
    Aparicio-Ozores, Gerardo
    Castelan-Vega, Juan A.
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2020, 88 (88)